Delta Financial Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
VCM
VPM
Delta Financial Advisors's VRTX Position: Q1 2026 in Review
Delta Financial Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 1% in Q1 2026, selling an estimated $4.2K and leaving 863 shares worth $385K. The position accounts for 0.1% of the portfolio, ranked #123.
Delta Financial Advisors first reported a position in VRTX in Q2 2023 and has held it in 12 quarters since. The position peaked at $395K in Q4 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Delta Financial Advisors held 863 shares of Vertex Pharmaceuticals worth $385K as of Q1 2026.
- Delta Financial Advisors sold 9 Vertex Pharmaceuticals shares in Q1 2026, an estimated $4.2K.
- Vertex Pharmaceuticals made up 0.1% of Delta Financial Advisors's portfolio in Q1 2026, its #123 holding.
- Delta Financial Advisors first reported a position in Vertex Pharmaceuticals in Q2 2023 and has held it in 12 quarters since.
- Delta Financial Advisors's Vertex Pharmaceuticals position peaked at $395K in Q4 2025.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Delta Financial Advisors's 13F filing for Q1 2026, filed 5 May 2026.